[1] Eisenhauer E A, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)[J]. European Journal of Cancer, 2009, 45(2): 228-247.
[2] 汪俊萍, 廖茜, 张云亭, 等. 良恶性淋巴结鉴别的影像学研究进展[J].医学综述, 2011, 17(6): 925-928. Wang Junping, Liao Qian, Zhang Yunting, et al. Advancement of differentiatial imaging of benigan and maglignant lymph nodes[J]. Medical Recapitulate, 2011, 17(6): 925-928.
[3] 邵娴, 刘辉, 时高峰. 磁共振弥散加权成像在早期评估食管癌放疗疗效的应用价值[J]. 河北医药, 2013, 35(22): 3403-3404. Shao Xian, Liu Hui, Shi Gaofeng. The value about diffusion weighted magnetic resonance imaging in the early assessment of efficacy of radiotherapy in esophageal cancer[J]. Hebei Medical Journal, 2013, 35 (22): 3403-3404.
[4] Lambregts D M, Beets G L, Maas M, et al. Tumour ADC measurements in rectal cancer: Effect of ROI methods on ADC values and interobserver variability[J]. European Radiology, 2011, 21(12): 2567-2574.
[5] Thoeny H C, De Keyzer F, Chen F, et al. Diffusion- weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats[J]. Radiology, 2005, 234(3): 756-764.
[6] Park S Y, Kim C K, Park B K, et al. Early changes in apparent diffusion coefficient from diffusion-weighted MR imaging during radiotherapy for prostate cancer[J]. International Journal of Radiation Oncology Biology Physics, 2012, 83(2): 749-755.
[7] Imanishi S, Shuto K, Aoyagi T, et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting the early response to chemoradiotherapy of advanced esophageal squamous cell carcinoma[J]. Digestive Surgery, 2013, 30(3): 240-248.
[8] 时高峰, 高红梅, 刘辉, 等. 磁共振扩散成像技术对食管癌放疗后疗效评价的动态研究[C] //第五届中国肿瘤学术大会暨第七届海峡两岸肿瘤学术会议、国际肿瘤细胞与基因治疗学会会议、第二届中日肿瘤介入治疗学术会议, 中国石家庄, 2008. Shi Gaofeng, Gao Hongmei, Liu Hui, et al. MRI diffusion imaging dynamic assessing esophageal carcinoma preradiation therapy and after radiation therapy[C] //Fifth China Oncology Conference and the Seventh Cross- Strait Academic Conference Tumors, Tumor Cells and the International Society of Gene Therapy Meeting, the Second Sino- Japanese Interventional Treatment of Cancer Conference, Shi Jiazhuang, China, 2008.
[9] Makino H, Kato H, Furui T, et al. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for uterine cervical cancer[J]. Journal of Obstetrics and Gynaecology Research, 2014, 40(4): 1098-1104.
[10] Cai G, Xu Y, Zhu J, et al. Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation[J]. World Journal of Gastroenterology, 2013, 19(33): 5520-5527.
[11] De Paepe K, Bevernage C, De Keyzer F, et al. Whole-body diffusionweighted magnetic resonance imaging at 3 Tesla for early assessment of treatment response in non- Hodgkin lymphoma: A pilot study[J]. Cancer Imaging, 2013, 13(1): 53-62.
[12] Chen Y, Zhong J, Wu H, et al. The clinical application of whole-body diffusion-weighted imaging in the early assessment of chemotherapeutic effects in lymphoma: The initial experience[J]. Magnetic Resonance Imaging, 2012, 30(2): 165-170.
[13] Wu X, Nerisho S, Dastidar P, et al. Comparison of different MRI sequences in lesion detection and early response evaluation of diffuse large Bcell lymphoma- a whole- body MRI and diffusion- weighted imaging study[J]. NMR in Biomedicine, 2013, 26(9): 1186-1194.
[14] Ohno Y, Koyama H, Yoshikawa T, et al. Diffusion-weighted MRI versus 18F- FDG PET/CT: Performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy[J]. American Journal of Roentgenology, 2012, 198(1): 75-82.
[15] Zheng D, Chen Y, Chen Y, et al. Early assessment of induction chemotherapy response of nasopharyngeal carcinoma by pretreatment diffusion-weighted magnetic resonance imaging[J]. Journal of Computer Assisted Tomography, 2013, 37(5): 673-680.
[16] Barbaro B, Vitale R, Valentini V, et al. Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy[J]. International Journal of Radiation Oncology Biology Physics, 2012, 83(2): 594-599.
[17] Musio D, De Felice F, Magnante A L, et al. Diffusion-weighted magnetic resonance application in response prediction before, during, and after neoadjuvant radiochemotherapy in primary rectal cancer carcinoma[J]. BioMed Research International, 2013, Article ID: 740195.1-5
[18] Craciunescu O I, Thrall D E, Vujaskovic Z, et al. Magnetic resonance imaging: A potential tool in assessing the addition of hyperthermia to neoadjuvant therapy in patients with locally advanced breast cancer[J]. International Journal of Hyperthermia, 2010, 26(7): 625-637.
[19] Chen J, Daniel B L, Diederich C J, et al. Monitoring prostate thermal therapy with diffusion- weighted MRI[J]. Magnetic Resonance in Medicine, 2008, 59(6): 1365-1372.
[20] Reichardt W, Juettner E, Uhl M, et al. Diffusion-weighted imaging as predictor of therapy response in an animal model of Ewing sarcoma[J]. Investigative Radiology, 2009, 44(5): 298-303.
[21] Ohira T, Okuma T, Matsuoka T, et al. FDG-MicroPET and diffusionweighted MR image evaluation of early changes after radiofrequency ablation in implanted VX2 tumors in rabbits[J]. Cardiovascular and Interventional Radiology, 2009, 32(1): 114-120.
[22] 徐继飞, 王凡. 磁共振成像在鼻咽癌放射治疗中的应用[J]. 国际肿瘤学杂志, 2012, 39(2): 127-130. Xu Jifei, Wang Fan. Applications of magnetic resonnance imaging in radiotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2012, 39(2): 127-130.
[23] 司家文, 史宏璐, 刘哲, 等. 磁共振弥散加权成像在口腔鳞癌颈部淋 巴结转移中的初步应用[J]. 中国口腔颌面外科杂志, 2012, 10(4): 311-315. Si Jiawen, Shi Honglu, Liu Zhe, et al. Initial study of diffusionweighted magnetic resonance imaging for cervical lymph node metastases in patients with oral squamous cell carcinoma[J]. China Journal of Oral & Maxillofacial Surgery, 2012, 10(4): 311-315.
[24] Wu L M, Xu J R, Gu H Y, et al. Preoperative mediastinal and hilar nodal staging with diffusion- weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non- small- cell lung cancer: Which is better?[J]. Journal of Surgical Research, 2012, 178(1): 304-314.
[25] 金征宇, 薛华丹. 全身弥散加权成像肿瘤学临床应用图谱[M]. 北京:科学出版社, 2009. Jin Zhengyu, Xue Huadan. Atlas of whole body diffusion weighted imaging in oncological clinical application[M]. Beijing: Science Press, 2009.
[26] Tsuchida T, Morikawa M, Demura Y, et al. Imaging the early response to chemotherapy in advanced lung cancer with diffusion- weighted magneticresonance imagingcomparedtofluorine-18fluorodeoxyglucose positron emission tomography and computed tomography[J]. Journal of Magnetic Resonance Imaging, 2013, 38(1): 80-88.
[27] Weber M A, Bender K, von Gall C C, et al. Assessment of diffusionweighted MRI and 18F- fluoro- deoxyglucose PET/CT in monitoring early response to neoadjuvant chemotherapy in adenocarcinoma of the esophagogastric junction[J]. Journal of Gastrointestinal and Liver Diseases, 2013, 22(1): 45-52.
[28] Hagtvedt T, Seierstad T, Lund K V, et al. Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma[J]. Acta Radiologica, 2014, pii: 0284185114526087.
[29] Heijmen L, Verstappen M C, Ter Voert E E, et al. Tumour response prediction by diffusion-weighted MR imaging: ready for clinical use?[J]. Critical Reviews in Oncology Hematology, 2012, 83(2): 194-207.
[30] Thoeny H C, De Keyzer F, King A D. Diffusion-weighted MR imaging in the head and neck[J]. Radiology, 2012, 263(1): 19-32.
